Skip to main content
FinSpry Logo
FinSpry
SUPN logo
SUPN
(NASDAQ)
Supernus Pharmaceuticals, Inc.
$47.64-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Supernus Pharmaceuticals (SUPN) Stock Price & Financial Analysis

Supernus Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$46.47 - $47.72
52-Week High$59.68
52-Week Low$40.32
Open$47.11
Volume725.37K
Average Volume (3M)1.02M
Market Cap2.75B
Shares Outstanding57.65M
Price to Sales (P/S)3.54
Price to Book (P/B)2.55
EV/EBITDA57.91
Revenue (TTM)776.83M
Net Income (TTM)-29.02M
Free Cash Flow (TTM)82.25M
EPS (TTM)$-0.51
Profit Margin-3.74%
Operating Margin-5.37%
Return on Equity (ROE)-2.69%
Debt to Equity0.04
50-Day MA$46.18
200-Day MA$48.90
52-Week Change15.55%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Supernus Pharmaceuticals

What is the current stock price for SUPN?

As of the latest trading session, SUPN stock trades at $47.07. The 52-week range is $40.32–$59.68, with a day range of $46.47–$47.72.

What is the P/E ratio for SUPN?

The P/E ratio (Price-to-Earnings) for SUPN is shown in the Key Statistics section. This valuation metric helps compare Supernus Pharmaceuticals, Inc. to industry peers.

Does SUPN pay dividends?

Supernus Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SUPN?

Based on 4 analysts, the consensus for SUPN is Buy.

What is the market cap of SUPN?

Supernus Pharmaceuticals's market capitalization is $2.71B, classifying it as a mid-cap company. Supernus Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.